Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2968 Target Snapshot

Tyrosine-protein kinase JAK1 · SINGLE PROTEIN · Mus musculus

14Compounds
16Assays
2Approved Drugs
10.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P52332. Use UniProt P52332 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P52332 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tyrosine-protein kinase JAK1 as ChEMBL target CHEMBL2968, mapped to UniProt P52332. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tyrosine-protein kinase JAK1
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL2968
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P52332
Tyrosine-protein kinase JAK1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tyrosine-protein kinase JAK1 is the right protein anchor across sources, using UniProt P52332 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTyrosine-protein kinase JAK1
UniProt AccessionP52332
Component TypeProtein
Sequence Length1153 aa

Tyrosine-protein kinase JAK1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tyrosine-protein kinase JAK1, mapped to UniProt P52332. Sequence length is 1153 aa.

Mapped IDP52332
Review nameTyrosine-protein kinase JAK1
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC5010.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3622821 7.85 IC50 14.0 Approved
CHEMBL21156 7.82 IC50 15.0 Preclinical
CHEMBL3622826 7.3 IC50 50.0 Preclinical
CHEMBL5542400 6.92 IC50 120.0 Preclinical
CHEMBL5563563 6.64 IC50 230.0 Preclinical
CHEMBL221959 6.59 IC50 258.0 Approved
CHEMBL3116050 6.58 IC50 260.0 Preclinical
CHEMBL5566342 6.39 IC50 408.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
1
6.0
4
6.5
1
7.0
4
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

UPADACITINIB
CHEMBL3622821
Approved 2019
TOFACITINIB
CHEMBL221959
Approved 2012
Assay Landscape

Assay Landscape

16
Total Assays
9
Tested Compounds
1
Assay Types
Binding — 16 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 13 8 7.0
single protein format 3 1 7.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine